NCT05413278

Brief Summary

Main aims of this project are

  • To assess the baseline status-quo of transition and "fitness for transfer" in terms of information about the adult centre and team, organisational and practical skills (blood sampling and sending, how to make an appointment etc.), disease- and treatment-related knowledge, health-related quality of life (HrQoL), and self-efficacy in adolescnets with inborn errors of metabolism. Biochemical or physical parameters as appropriate for the respective diseases from 12 months before are documented.
  • To provide targeted, structured intervention modules (using available and, if necessary, adapted materials).
  • To measure the effects of these interventions on information about adult services short-term (within a month) and to re-assess all other baseline status-quo parameters long-term (6 and 12 months later). Psychological assessments will be complemented by biochemical or physical parameters as appropriate for the respective diseases and indicative for transition success.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Typical duration for not_applicable

Geographic Reach
2 countries

8 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 25, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 10, 2022

Completed
1.6 years until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

August 6, 2024

Status Verified

August 1, 2024

Enrollment Period

1.7 years

First QC Date

May 25, 2022

Last Update Submit

August 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Disease knowledge

    interview, semistructured

    change from baseline to 1 month

Study Arms (1)

Training

OTHER

Patient education, empowerment, and information

Behavioral: Behavioral

Interventions

BehavioralBEHAVIORAL

Patient education, information and empowerment

Training

Eligibility Criteria

Age14 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • with an inborn error of metabolism in the care of a specialized metabolic care unit
  • requiring specialized adult metabolic care
  • at least 14 years old
  • with a disease for which at least one biochemical and / or physical parameter disease marker is well established .

You may not qualify if:

  • Patients -
  • with insufficient knowledge of the German
  • with cognitive impairment to a degree that consent, and participation would be impossible
  • in an end-of-life situation
  • with a disease for which no biochemical and / or physical parameter disease marker is well established

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

University Childrens Hospital Vienna

Vienna, 1090, Austria

RECRUITING

University Hospital Vienna

Vienna, 1090, Austria

RECRUITING

University Childrens Hospital Basel

Basel, Switzerland

RECRUITING

University Hospital Basel

Basel, Switzerland

RECRUITING

University Childrens Hospital Bern

Bern, Switzerland

RECRUITING

University Hospial Bern

Bern, Switzerland

RECRUITING

University Childrens Hospital Zürich

Zurich, 8032, Switzerland

RECRUITING

University Hospital Zurich

Zurich, Switzerland

RECRUITING

MeSH Terms

Conditions

Metabolism, Inborn Errors

Condition Hierarchy (Ancestors)

Genetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2022

First Posted

June 10, 2022

Study Start

January 1, 2024

Primary Completion

September 1, 2025

Study Completion

December 31, 2025

Last Updated

August 6, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations